Navidea Biopharmaceuticals Inc NAVB:NYSE American

RT Quote | NYSE American | USD
Last | 05/19/22 EDT
0.90quote price arrow up+0.08 (+9.76%)
Volume
22,903
52 week range
0.72 - 2.19
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.90
  • 52 Week High2.19
  • 52 Week High Date06/07/21
  • 52 Week Low0.72
  • 52 Week Low Date05/13/22

Key Stats

  • Market Cap27.32M
  • Shares Out30.36M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-10

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.90
  • 52 Week High2.19
  • 52 Week High Date06/07/21
  • 52 Week Low0.72
  • 52 Week Low Date05/13/22
  • Market Cap27.32M
  • Shares Out30.36M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-10

RATIOS/PROFITABILITY

  • EPS (TTM)-0.40
  • P/E (TTM)-2.25
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-11.983M
  • ROE (TTM)-1,940.86%
  • Revenue (TTM)530,000.00
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-2,207.05%
  • Debt To Equity (MRQ)-425.52%

EVENTS

  • Earnings Date08/13/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Navidea Biopharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. Its business is focused on two primary types of drug products, such as diagnostic substances, including Tc99m...
Alexander Cappello
Chairman of the Board
John Scott Jr.
Vice Chairman of the Board
Address
4995 Bradenton Ave Ste 240
Dublin, OH
43017-3552
United States

Top Peers

SYMBOLLASTCHG%CHG
CYTH
Cyclo Therapeutics Inc
2.05-0.09-4.21%
TMBR
Timber Pharmaceuticals Inc
0.2649+0.0199+8.12%
ACUR
Acura Pharmaceuticals Inc
0.53UNCHUNCH
TRVN
Trevena Inc
0.2456-0.0272-9.9707%
ACRX
AcelRx Pharmaceuticals Inc
0.2892+0.0626+27.63%